UBS Group »

Inhibikase Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Inhibikase Therapeutics

Nov 2023Jan 2024Mar 2024May 2024Jul 2024Sep 2024Nov 2024Jan 2025020k40k60k80k010k20k
Value ($)Share countHistorical IKT position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $90k 28k 3.25
2024-09-30 $6.3k 4.9k 1.30
2024-03-31 $6.9k 3.2k 2.16
2023-09-30 $207 149 1.39